LIBROS
Zanchetta JR, Talbot JR. Osteoporosis: Fisiopatología, diagnóstico, prevención y tratamiento. Buenos Aires: Panamericana; 2001.
Ribera Casado JM, Gil Gregorio P, eds. El hueso del mayor y sus trastornos. XVIII Clínicas Gerontológicas. Madrid: EDIMSA; 2001.
Rapado Errazti A, Díaz Curiel M. Bisfosfonatos en las enfermedades del metabolismo óseo y mineral. Madrid: FHOEMO; 2002.
SECOT. Caídas en fractura de cadera. Madrid: SECOT; 2001.
NUMEROS MONOGRAFICOS
Lindsay R, ed. Advaces with bisphosphonates in the treatment of metabolic bone diseases. Osteoporosis Int 2001;12(Supp 3):1-22.
NUESTROS AUTORES
Almirall J, Ponz E, López T, Trallero R, Valls R, Rodríguez A, et al. Evaluación del metabolismo óseo en largo plazo en los pacientes con hipoparatiroidismo relativo tras cambiar la concentración de calcio del dializado a 3 mEq/L. Nefrología 2001;21:485-95.
Tanaka T, Latorre MR, Jaime PC, Florindo AA, Pippa MGB, Zerbini CA. Risck factors for proximal femur osteoporosis in men aged 50 years or older. Osteoporosis Int 2001;12: 942-9.
Hernández JL, Fidalgo I, López M, Olmos JM, González J. Diagnóstico de osteoporosis mediante la radiografía lateral de tórax. Med Clin (Barc) 2001;117:734-6.
Badía X, Díez-Pérez A, Álvarez Sanz C, et al. Measuring quality of life in women with vertebral fractures due to osteoporosis; a comparison of the OQLQ and QUALEFFO. Qual Life Res 2001;10:307-17.
López-Herce JA, del Castillo A, Teigell L, et al. Osteoporosis en enfermos ingresados en un servicio de medicina interna de un hospital general universitario. An Med Interna 2001;18:121-3.
Naves M, Díaz JB, Rodríguez A, et al. Efecto de la fractura vertebral sobre la calidad de vida en una población española mayor de 54 años. Med Clin (Barc) 2001;116:533-5.
Díaz Curiel M, Carrasco JJ, Carrasco JL, Honorato J, et al. Prevalencia de osteoporosis medida por densitometría en una población femenina española. Med Clin (Barc) 2001;116:86-8.
Moreno R, Ruiz MD, Artacho R, et al. Dietary intake of calcium, magnesium and phosphorus in an elderly population using duplicate diet sampling vs food composition tables. J Nutr Health Aging 2001;5:253-5.
Marco M, San Millán JL, Wuys W, et al. Lack of mutations in the RANK gene in Spanish patients with Paget disease of bone. Clin Genet 2001;60:86-8.
Orozco López P. Actualización en el abordaje y tratamiento de la osteoporosis 2001. Inf Ter Sist Nac Salud 2001;25:117-41.
Bernad M, Martínez ME, Escalona M, González ML, González C, Garcés MV, et al. Polymorphism in the type I collagen (COLIA 1) gen and fractures in postmenopausal women. Bone 2002;30:223-7.
Se ruega a los autores enviar una copia del trabajo para incluir su cita en esta Sección.
REVISIONES
Lyritis GP, Boscainos PJ. Calcitonin eeffet on cartilage and fracture healing. J Musculoeskel Neuron Interact 2001;2:137-42.
Rittweger J, Raunsch F. What is new in neuro-musculoskeletal interactions? J Musculoeskel Neuron Interact 2001;2:177-80.
Banks G.P., Berrington A, Casabonne D. Overview of the relationship between use of progresterone-only contraceptives and bone mineral density. Br J Obst Gynecol 2001;108: 1214-21.
Lories RJ, Luyten FP. Osteoprogetegerin and osteoprotegerin-ligand balance: a new paradigmm in bone metabolism providing new therapeutic targets. Clin Rheumatol 2001;20: 3-9.
Sheeghan D, Bennett T, Cashman KD. An assessment of genetic markers as predictor of bone turnover in healthy adults. J Endocrinol Invests 2001;24:236-45.
Massart F, Reginster JY, Brandi ML. Genetics of menopause-associated diseases. Maturitas 2001;40:103-16.
Chesnut CH, Rosen CJ for the Bone Quality Discussion Group. Reconsidering the effects of antiresortive therapies in reducing osteoporotic fractures. J Bone Miner Res 2001;16: 2163-72.
Riggs BL, Melton LJ. Bone turnover matters: The raloxifene treatment paradox of dramatic decreases in vertebral facture without commensurate increases in bone density. J Bone Miner Res 2002;17:11-4.
Delmas PD. Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in potsmenopausal osteoporosis. Bone 2002;30:14-7.
OTROS ARTÍCULOS DE INTERÉS
Kiel DP, Hannan MT, Broe KE, et al. Can metacarpal cortical area predict the occurrence of hip fracture in women and men over 3 decades of follow-up? Results from the Framingham Osteoporosis Study. J Bone Mine Res 2001;16:2260-5.
Cauley JA, Zmuda JM, Ensrud KE, Bauer DC, Ettinger B for the Study of Osteoporotic fractures Research Group. Timing of estrogen replacement therapy for optimal osteoporosis prevention. J Clin Endocrinol Metab 2001;86: 5700-5.
Armour KJ, Armour KE, Van Hof RJ, Reid DM, Wei X-Q, Liew FY, Ralston SH. Actiation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppresing bone formation and causing osteoblast apoptosis. Arth & Rheumat 2001;2790-6.
Adachi JD, Ioannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling mend and women across Canada. Osteoporosis Int 2001;12:903-8.
Mishal AA. Effects of different dresss styles on vitamin D levels in healthy young jordanian women. Osteoporosis Int 2001;12:931-5.
Magnusson H, Linden C, Karlsson C, Obrant KJ, Karlsson MK. Exercise may induce reversible low bone mass in unloaded and high bone mass in weight-loaded skeletal regions. Osteoporosis Int 2001;12:950-5.
Melton III LJ, Brown RD, Achenbach SJ, O'Fallon WM, Whisnant PJ. Long-term fracture risk following ischemic stroke: a population-based study. Osteoporosis Int 2001;12:980-6.
Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, Jonsson B. Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thrresholds. Osteoporosis Int 2001;989-95.
Dey J, Creighton A, Lindberg JS, Fuselier HA, Kok DJ, Cole FE, Hamm LL. Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis. J Urol 2002;167:169-71.
Tucker KL, Hannan MT, Kiel DP. The acid-base hypothesis: diet and bone in the Framingham Osteoporosis Study. Am J Nutr 2001;40:231-7.
Löfman O, Berglund K, Larsson L, Toss G. Changes in hip fracture epidemiology: Redistribution between ages, genders and fracture types. Osteoporosis Int 2002;13:18-25.
Need AG, Kemp A, Giles N, Morris HA, Horowitz M, Nordin BE. Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women. Osteoporosis Int 2002;13:83-8.
Crabtree NJ, Kroger H, Martin A, Pols HAP, Lorenc R, Nijs J, et al. Improving risk assessment: Hip geometry, bone mineral disstribution and bone strength in hip fracture aces and controls. The EPOS Study. Osteoporosis Int 2002;13: 248-54.
Duan Y, Seeman E, Turner CH. The biomechanical basis of vertebral body fragility in men and women. J Bone Miner Res 2001;16:2276-83.
Friedrichs WE, Reddy SV, Bruder JM, Cundy T, Cornish J, Sinnger FR, Roodman GD. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res 2002;17:145-51.
Heshmati HM, Khosla S, Robins SP, O'Fallon WM, Melton LJ, Riggs BL. Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 2002;17:172-8.
Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Davis J. Tenyear risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 2002;30:251-8.
Asukara H, Myou S, Ontachi Y, Mizutani T, Kato M, Morishita E, et al. Vitamin K administration to elderly patients with osteoporosis induces no hemostatic activation, even in those with suspected vitamin K deficiency. Osteoporosis Int 2001;12:996-1000.
Tosteston ANA, Gabriel SE, Grove MR, Moncur MM, Kneeland TS, Melton LJ. Impact of hip and vertebral fractures on quality-adjusted life years. Osteoporosis Int 2001;12:1042-9.